Aristolochic Acid and Herbal Nephropathy: A Documented Herbal Harm
Aristolochic acid in some Aristolochia herbs has caused kidney failure and urinary tract cancers. See where it was found, how substitution happened and what to ask a clinician.
Content last updated . This page has not been medically reviewed.
Safety first. Supplements can cause side effects and interact with medicines. Read mushroom safety and interactions before you use any mushroom product.
Safety first. Aristolochic acid (AA) is a plant compound that has caused a kidney disease called aristolochic acid nephropathy, often linked with cancers of the urinary tract. [1][2] If you have used a product that may have contained it, tell a doctor, ideally a kidney specialist, and name the product. A Taiwan study of people with kidney failure concluded that regular follow-up screening for urinary tract cancer is necessary after use of such products. [3]
What aristolochic acid is
Aristolochic acid is an abundant compound in Aristolochia plants (family Aristolochiaceae) and various other natural herbs. [4] Plant names change: GBIF now lists Aristolochia fangchi as a synonym of Isotrema fangchi. [5] Three plants appear in the main reports: A. fangchi in Belgian slimming pills, A. manshuriensis ("Guan Mu Tong") in Taiwan, and A. clematitis, whose seeds contaminated wheat flour in the Balkans. [1][3][6]Traditional use
This is tradition, not proof. A 2026 review says Aristolochia species have long been used in traditional medicine for presumed anti-inflammatory, pain-relieving and germ-fighting effects. [7] A 2013 review reports that in Taiwan one-third of the population had been prescribed herbal remedies containing Aristolochia. [2] The reports below concern one compound and mix-ups in products, not traditional Chinese medicine as a whole; the 2008 review ties the risk to frequent substitution of herbs by AA-containing ones. [1]How the harm was found
| Setting | What the source found | Strength of evidence |
|---|---|---|
| Belgian slimming pills (1990s) | A cohort of more than 100 patients developed progressive kidney scarring, frequently with urothelial cancer, after pills containing a Chinese herb, A. fangchi. [1] A manufacturing error had replaced Stephania tetrandra with it. [8][9] | Evidence of harm (patient cohort) |
| Belgian transplant and dialysis patients | Among 39 patients who had preventive surgery, 18 had urothelial carcinoma (46%), and all samples carried AA-related DNA changes. [8] | Evidence of harm (cohort) |
| Taiwan, people with kidney failure | In 38,995 patients, being prescribed Mu Tong adulterated with A. manshuriensis before 2004 was linked to higher urinary tract cancer risk. [3] | Observational; association |
| Balkans | Flour from wheat contaminated with A. clematitis seeds could explain Balkan endemic nephropathy. [1] A 2026 review calls the link to this disease and to urinary tract cancer strong. [7] | Strong epidemiological association |
| Liver cancer | A 2019 review notes an AA signature linked to liver cancer, but a lack of clarity on whether AA causes it. [4] | Insufficient evidence |
Proper evidence not found, in the sources we read, of a benefit from Aristolochia products that offsets these harms. A 2019 review says opinions differ on whether AA-containing Chinese medicines should be used. [4] A 2026 review urges replacing Aristolochia-based preparations with validated, safer alternatives. [7]
Frequently asked questions
What is aristolochic acid nephropathy?
A progressive scarring of the kidney's tissue, frequently associated with cancers of the urinary lining, first reported in a Belgian group using slimming pills. [1]
Which herbs contain aristolochic acid?
Reports name Aristolochia species such as A. fangchi, A. manshuriensis and A. clematitis. [1][3] Products may be mislabeled, so a name alone is not a guarantee. [8]
Is all Chinese herbal medicine affected?
The sources tie the harm to AA-containing herbs and to substitution, not to every herb. [1] Ask a pharmacist about any specific product.
Can I still buy these herbs?
A 2008 review said they were still sold on the internet despite FDA warnings. [1]
What should I do if I used one?
Tell a doctor and name the product. Screening for urinary tract cancer was advised for kidney-failure patients who had used such products. [3] Do not stop a prescribed medicine without asking the prescriber.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
What regulators say
- botanicals known or suspected to contain AA were no longer permitted in many countries, and the FDA had warned about them, yet such herbs were still sold on the internet in 2008; [1]
- countries have taken different measures; [4]
- regulatory responses remain inconsistent across regions. [7]
For the Chinese medicine context, see Aristolochic acid and kidney injury, Chinese herbs with known safety concerns and adulteration and substitution in Chinese herbs. For banned ingredients in general, see banned and restricted ingredients.
Who should ask first
References
- Debelle FD et al., Aristolochic acid nephropathy: a worldwide problem. Kidney International 2008. Read 2026-10-23.
- Grollman AP, Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environmental and Molecular Mutagenesis 2013. Read 2026-10-23.
- Increased risk of urinary tract cancer in end-stage kidney disease patients associated with Chinese herbal products suspected of containing aristolochic acid. PLoS One 2014. Read 2026-10-23.
- Recognition of the toxicity of aristolochic acid. Journal of Clinical Pharmacy and Therapeutics 2019. Read 2026-10-23.
- GBIF Backbone Taxonomy, Aristolochia fangchi match record. Read 2026-10-23.
- GBIF Backbone Taxonomy, Aristolochia clematitis match record. Read 2026-10-23.
- Beyond Tradition: an integrated toxicological, ecological and public health perspective on aristolochic acids. Journal of Applied Toxicology 2026. Read 2026-10-23.
- Nortier JL et al., Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New England Journal of Medicine 2000. Read 2026-10-23.
- GBIF Backbone Taxonomy, Stephania tetrandra match record. Read 2026-10-23.
- NCCIH, Using Dietary Supplements Wisely (US NIH). Read 2026-10-23.